文献速递胸部肿瘤放疗放疗物理与技术

MRI与CBCT在局部晚期非小细胞肺癌根治性放疗中淋巴结识别与配准的比较

MRI and CBCT for lymph node identification and registration in patients with NSCLC undergoing radical radiotherapy.
PubMed 文献 · Radiother Oncol · 2021-03-26

本研究对比MRI与CBCT在局部晚期非小细胞肺癌患者淋巴结识别与配准中的表现,由放疗技师对24个淋巴结进行图像质量视觉分级分析及配准置信度评分。结果显示MR1和MR2序列图像质量显著优于CBCT(p≤0.01),观察者间配准变异性无显著差异,但MR配准置信度更高(p≤0.02),提示MRI序列在MR引导放疗工作流中具有应用前景。

要点

  • MR1和MR2序列图像质量显著优于CBCT(p≤0.01)。
  • CBCT与MRI序列间淋巴结配准观察者间变异性无显著差异。
  • 观察者对MR配准的置信度显著高于CBCT(p≤0.02)。

核心结论

  • CBCT与MRI序列间观察者间配准校正变异性无显著差异,但MRI序列图像质量和配准置信度更优,是迈向MR引导放疗治疗LA-NSCLC的有前景的一步。

研究设计与样本

  • 放疗技师对24个淋巴结在CBCT和两个MR序列(MR1:T2w Turbo Spin Echo;MR2:T1w DIXON water only image)上进行图像质量视觉分级分析、淋巴结配准及配准置信度评分。

主要发现

  • 配准前图像质量评估显示MR1和MR2在图像质量方面显著优于CBCT(p≤0.01)。
  • CBCT、MR1和MR2之间淋巴结配准的观察者间变异性无显著差异。
  • 观察者对MR配准的置信度高于基于CBCT的淋巴结配准(p≤0.02)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study compared MRI to CBCT for the identification and registration of lymph nodes (LN) in patients with locally advanced (LA)-NSCLC, to assess the suitability of targeting LNs in future MR-image guided radiotherapy (MRgRT) workflows. METHOD: Radiotherapy radiographers carried out Visual Grading Analysis (VGA) assessment of image quality, LN registration and graded their confidence in registration for each of the 24 LNs on CBCT and two MR sequences, MR1 (T2w Turbo Spin Echo) and MR2 (T1w DIXON water only image). RESULTS: Pre-registration image quality assessment revealed MR1 and MR2 as significantly superior to CBCT in terms of image quality (p ≤ 0.01). No significant differences were noted in interobserver variability for LN registration between CBCT, MR1 and MR2. Observers were more confident in their MR registrations compared to their CBCT based LN registrations (p ≤ 0.02). SUMMARY: Interobserver setup correction variability was not found to be significantly different between CBCT and MR. Image quality and registration confidence were found to be superior for MRI sequences. This is a promising step towards MR-guided radiotherapy for the treatment of LA-NSCLC.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Dubec M, Brown S, Chuter R, et al. MRI and CBCT for lymph node identification and registration in patients with NSCLC undergoing radical radiotherapy. Radiother Oncol. 2021. PMID: 33775713. doi:10.1016/j.radonc.2021.03.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。